Former DU chancellor Rebecca Chopp stepped down from the University of Denver’s top post after her diagnosis. Years later, she found out she probably didn’t have the disease to begin with.
Read the story HERE
Former DU chancellor Rebecca Chopp stepped down from the University of Denver’s top post after her diagnosis. Years later, she found out she probably didn’t have the disease to begin with.
Read the story HERE
Alzheimer’s disease is notoriously tricky to diagnose, with symptoms creeping in so gradually that they can easily be mistaken for something else entirely. Yet pinpointing the signs early can make all the difference in slowing its progression. Among these early red flags, language issues are often ignored or underestimated—but they might just be your best tool for picking up on Alzheimer’s sooner.
Read more HERE
In an interview with Pharmacy Times, Carolyn Fredericks, MD, assistant professor of neurology at Yale University, highlighted at the 2026 AAN annual meeting that MRI and PET studies show women in their 40s and 50s experience changes in brain connectivity—especially in memory circuits—linked to declining estrogen during menopause.
Read more HERE
New research suggests that the balance and walking issues associated with Alzheimer’s disease may not be “top-down” problems caused by brain decay, but rather “bottom-up” failures in the peripheral nervous system.
The study utilized “human-on-a-chip” technology to prove that genetic mutations for familial Alzheimer’s can damage the connection between nerves and muscles directly, independent of the brain or spinal cord.
Read it HERE
Drugs once hailed as a breakthrough in the fight against Alzheimer’s disease do not meaningfully help patients, a major review found Thursday, however some experts criticized the research.
The review by the Cochrane organization – which is considered the gold standard for analyzing existing evidence – looked at drugs that target a plaque called amyloids, which builds up in the brains of Alzheimer’s patients.
Read more HERE
More than 30% of adults over 70 have amyloid or tau (proteins implicated in the development of Alzheimer’s disease) in their brains yet have no apparent cognitive problems. This may indicate greater cognitive reserve, the brain’s ability to compensate for damage.
See more HERE